Privacy Statements and Cookie Policy

The protection of personal information

In the regular course of business, Baxalta Incorporated ("Baxalta") acquire personal information by interaction and communication with patients, healthcare professional, employees, and others. Baxalta recognizes and respects the privacy rights of individuals with regards to such personal information. As evidence of its commitment to privacy, Baxalta's management has established the Global Privacy Policy ("Policy") to ensure that respect for privacy is a key part of Baxalta company culture and operations.

If you should have any questions concerning Baxalta's privacy practices or wish to access or correct personal information that Baxalta has collected from you, please contact Global.Privacy.Office@baxalta.com for further information.

Global Privacy Policy

Baxalta's full privacy policy can be accessed here.

Privacy & Websites

Since Baxalta has many websites developed by Baxalta business units and regions that can be accessed via the www.Baxalta.com site please see the information in the following section for further information about privacy and websites.

You can access a number of individual sites developed by Baxalta businesses ("Baxalta Sites") through www.Baxalta.com. The privacy practices of Baxalta Sites generally conform to the Global Privacy Policy. Collection and processing of Personal Information, however, may vary with the unique features of each site. Therefore, where applicable, you are encouraged to review the terms of the individual privacy policy that is tailored for the specific Baxalta site you are visiting. Baxalta is not responsible for the content or privacy practices of sites linked to www.Baxalta.com or any other Baxalta sponsored website that are not developed by Baxalta businesses. You are encouraged to review the privacy policies of each website you visit.

In many instances, we collect personally identifiable information solely for the purpose of providing you with information you have requested about products or services. If we intend to use your information to provide you with information about other products or services that we think might be of interest to you or for any other purpose, we will provide a notice of our intention on the part of the site where your request is collected and you will have the option of refusing to receive this additional information.

Website collection practices for www.Baxalta.com:

Web Forms

Given the largely informative nature of our website, we collect a limited amount of personal information. For example: On our site, we have feedback forms that ask for your name, address and phone number, etc. so that we can send you information or answer your questions regarding Baxalta.

Cookies

This site also collects non-personal information. For example, like many websites, Baxalta.com may use "cookies". A cookie is a small file that is transferred to your computer's hard drive to help us to improve content (e.g., it helps us determine which parts of the site are popular and which are less popular, so we may improve these areas in the future) and customize website content and ads for our visitors. Cookies that we generate contain no personal information about you, and we will not combine cookie information with any personal information we have collected from you via this website. You may set your browser to reject cookies and to let you know when a cookie is being placed on your computer. This site also logs IP addresses and Internet browser types, but we do not link such information to your personal information.

Use of cookies may vary with the unique features of Baxalta websites. Therefore, please review the terms of the individual privacy policy that is tailored for the specific Baxalta website you are visiting for any additional information on the use of cookies by the particular Baxalta website.

Web Beacons

Our web pages contain electronic images (called a "single-pixel gif" or "Web beacon") that allow us to count page views or to access our cookies. In general, any electronic image viewed as part of a Web page, including an ad banner, can act as a Web beacon. Web beacons are typically very small, 1 by 1 pixel size, banner like files, but their presence can be easily seen within Internet Explorer by clicking on "View" and then on "Source." Web beacons are so small in order not to use valuable space on the computer screen that is better used to display helpful content. We also may include Web beacons in HTML-formatted newsletters containing graphics that we send to opt-in subscribers in order to count how many newsletters have been read. In addition, some advertising networks that serve ads on our Web sites may use Web beacons within in their clearly visible banner advertisements. Our Web beacons do not collect, gather, monitor or share any personal information about our Web site visitors. They are just the technique we use to compile our anonymous, aggregated statistics about Web site usage.

Computer Profiles

Through our technology, we also collect and accumulate other anonymous data that helps us understand and analyze the Internet experience of our visitors. For example, we accumulate visitor data relating to referring domains, the type of browsers used, operating system software (e.g. Windows XP or Vista), screen resolutions, color capabilities, plug-ins, language settings, cookie preferences, search engine keywords and JavaScript enablement. We also record number of visits, paths taken and time spent on sites and pages. None of this information is personally identifiable and we only share this information in the aggregate, reflecting overall Web site or Internet usage trends.

Internet Protocol (IP) Addresses

This Site uses Internet protocol (IP) addresses. IP addresses are unique identifiers automatically assigned to each computer when logging onto the Internet. IP addresses allow us to collect much of the same information we collect through cookies, including browser-type, what pages you visit, and how long you stay on the Site. In general, IP addresses allow us to identify problems with our servers, prepare aggregate demographic information and other information regarding this use of this Site, and improve the functions of this Site.

HIPAA Statement

Baxalta US Inc. is committed to identifying meaningful solutions to the challenges our customers face on various fronts. This customer commitment requires that we keep in step with industry legislative and regulatory initiatives such as the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"). HIPAA's privacy and security regulations require our customers to monitor and limit the ways in which patients' confidential information is accessed, utilized, stored, transmitted, and disposed.

If you have any questions regarding Baxalta and our HIPAA activities, please send us an email at Global.Privacy.Office@baxalta.com or leave a message on our Ethics and Compliance Helpline at: www.baxalta.com/compliance

Baxalta and the U.S.-EU and U.S.-Swiss Safe Harbors for Privacy

The U.S. Department of Commerce and the European Commission have developed a "safe harbor" framework of data protection principles ("U.S.-EU Safe Harbor Framework"). The U.S. Department of Commerce and the Federal Data Protection and Information Commissioner of Switzerland have developed a similar, but separate "safe harbor" framework of data protection principles ("U.S.-Swiss Safe Harbor Framework"). These frameworks are designed to provide U.S. organizations with a means to satisfy the European Union's or Switzerland's legal requirement that adequate data protections be afforded to personal information transferred from the European Union or Switzerland to the United States. Baxalta's Global Privacy Policy is consistent with the Safe Harbor Privacy Principles and Baxalta has specifically certified that its transfers of manual and electronic data from European Union or Switzerland to the United States adhere to the Safe Harbor Privacy Principles.

For more information on safe harbor, please see www.export.gov/safeharbor/

Baxalta's Global Complaint Handling and Dispute Resolution Procedure

Baxalta is committed to ensuring that complaints and disputes concerning Baxalta's privacy practices are investigated and resolved. For this reason, we have developed a privacy complaint handling procedure. It is our intention to resolve all complaints through this procedure.

The following is a summary of how our complaints and dispute process works. If you have any questions, please contact Baxalta's Ethics and Compliance Helpline at: www.baxalta.com/compliance, send an email to Global.Privacy.Office@baxalta.com.

Step 1: Complete and submit the complaint details via e-mail or the Ethics and Compliance Helpline or fax the information to Baxalta.

Step 2: Receive a communication from Baxalta acknowledging receipt of your complaint.

Step 3: Receive a communication from a Baxalta employee assigned to investigate your concern within five (5) business days of the day you receive the communication from Baxalta acknowledging receipt of your complaint.

Step 4: Baxalta will conduct an investigation into your complaint. During this process, you may receive additional communications from the Baxalta investigator.

Step 5: The investigator will contact you within fifteen (15) business days from the date he or she first contacted you with a proposed resolution to your concern. If you agree with the proposed resolution, you and the investigator will work together to close the matter. If you do not agree, the matter will be escalated to Baxalta's Global Privacy Officer.

Step 6: If you and the investigator cannot resolve your concern, the Baxalta Corporate Privacy Leader will take steps to resolve the matter. Within ten (10) business days of the escalation, Baxalta's Global Privacy Officer will contact you to propose a resolution.

Step 7: If you agree to the resolution, you will work with Baxalta's Global Privacy Officer to close the matter.

Step 8: If you and Baxalta's Global Privacy Officer do not agree to a resolution, we will offer you the opportunity to take the matter to an independent third party for resolution.

The information submitted by you will only be used to investigate and respond to your privacy inquiry.

Contact Us – Privacy

For general questions, contact us by phone, fax, or email at Baxalta's Ethics and Compliance Helpline at www.baxalta.com/compliance or send an email to Global.Privacy.Office@baxalta.com.

Providing your name and accurate contact information is not required, but will ensure Baxalta can respond to your feedback.

You Are Leaving Baxalta.com

You are about to leave Baxalta.com and go to a non-Baxalta website. Baxalta is not responsible for the privacy policy, the content or the accuracy of any website accessed through a link on Baxalta.com. A link to other websites does not constitute an endorsement by Baxalta of the linked site, its products or services. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living.

Baxalta Twitter Disclaimer

Content available from Baxalta's Twitter page is for informational purposes only. Baxalta may provide links or references to other sites as part of its tweet postings. However, Baxalta is not responsible for the privacy policy, the content or the accuracy of any website accessed through these links. A link to other websites does not constitute an endorsement by Baxalta of the linked site, its products or services.

Neither Baxalta Incorporated., nor its subsidiaries, commits to monitoring or responding to @ mentions/replies. If you would like to receive a response from the company, please visit here to contact the appropriate Baxalta department.

If you, or someone you know, have possibly experienced a side effect while taking or using a Baxalta product, please contact Baxalta Drug Safety by 800-999-1785 (phone) or 800-568-5020 (fax) if in the United States. In the United States, you may report to the U.S. Food and Drug Administration (FDA) by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. If you are a patient or healthcare provider located outside the United States, please report side effects to your country's health authorities.

This site may contain information on medical and health-related topics. This information is not meant to be a substitute for the advice provided by your own physician or other medical professional. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.

Baxalta reserves all rights relating to the company's Twitter account including, but not limited to, all rights to add, remove or modify any content or material posted on the account, discontinue the account, and respond to any questions or comments addressed to the account. The Baxalta logo and images on this page are the property of Baxalta Incorporated.

LinkedIn Community Guidelines

We’re excited that you want to connect with Baxalta on LinkedIn and look forward to hearing what you have to say! We ask anyone engaging in conversation with us on LinkedIn to respect the highly regulated industry in which we operate as well as our desire to keep the conversation professional and respectful. To that end, we need your help to provide a positive and productive experience for all participants and visitors.

Please note that any comments of the following nature are subject to removal:

1. Comments that offer health or medical guidance or are product related.
2. Comments including profane, threatening, offensive or defamatory language.
3. Comments insightful or suggestive of violent, illegal or threatening behaviors.
4. Comments in violation of legal ownership rights, including copyrights and intellectual property rights.
5. Comments including confidential information.
6. Comments that violate LinkedIn’s User Agreement.

If you, or someone you know, have possibly experienced a side effect while taking or using a Baxalta product, please contact Baxalta Drug Safety by 800-999-1785 (phone) or 800-568-5020 (fax) if in the United States. In the United States, you may report to the U.S. Food and Drug Administration (FDA) by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. If you are a patient or healthcare provider located outside the United States, please report side effects to your country's health authorities.